Pancreatic Cancer Targeted C-Visa-Bikdd: Dna-Liposome Complex Results in Minimal Toxicity in Vivo
M. M. Javle,X. Xie,W. Xia,Z. Li,H. Kuo,Y. Liu,Q. Ding,S. Zhang,B. Spohn,Y. Yang,Y. Wei,Y. Lang,J. L. Abbruzzese,M. C. Hung
2007-01-01
Molecular Cancer Therapeutics
Abstract:B152 Introduction: Gene therapy for pancreatic cancer is complicated by the need for a pancreatic cancer-specific promoter and the desmoplastic reaction within the tumor, thus making local delivery unreliable. We developed a versatile expression vector ‘‘VISA’’ (VP16-GAL4-WPRE integrated systemic amplifier) and a CCKAR (cholecystokinin type A receptor) gene-based, pancreatic-cancer-specific promoter VISA (CCKAR-VISA): liposome composite to target transgene expression systemically in pancreatic adenocarcinoma [Cancer Cell. 2007;12(1):52-65]. The acute toxic effects induced by systemic administration of this DNA:liposomal complex in C57BL/6 mice were studied. Methods: C57BL/6 mice randomly received 0.9 % normal saline (control:ctrl) i.p. or cerulein i.p. 50 µg/kg injections (to induce acute pancreatitis: positive ctrl) or 100 µl (2.5 mg/kg or 5 mg/kg) of the DNA:liposome complex. Pancreas was removed, frozen in liquid nitrogen, and stored at -800C. Tissue sections were also fixed in formaldehyde for histological and TUNEL analysis. Levels of serum AST, ALT, BUN and serum amylase activity [Phadebas Amylase Test Kit (Magle Life Sciences, Lund, Sweden)] were measured. To examine active trypsin, 25-ul aliquot of the pancreatic homogenate was incubated at 370C for 5 minutes in assay buffer and 50 ul of 400 uM trypsin substrate (Sigma, St Lois, MO). The plate was read using the CytoFluor Multi-Well Plate Reader (PE Biosystems, Foster City, CA) with an excitation at 380 nm and an emission at 440 nm. Trypsin activity was calculated according to a standard curve from purified trypsin (Sigma). Results: No differences were observed of the levels of serum amylase (p = 0.6) and pancreatic active trypsin activity (p = 0.1) between the C-VISA-BikDD-treated mice and the ctrl mice. In the positive ctrl group, cerulein resulted in elevated levels of serum amylase and pancreatic active trypsin activity. Histology of the pancreas from mice treated with C-VISA-BikDD showed no evidence of parenchymal edema, pancreatic epithelial vacuolization, necrosis, apoptosis or inflammatory cell infiltration. However, there was clear evidence of acute pancreatitis induced by cerulein. No TUNEL-positive cells appeared in the acinar and ductal cells of the pancreas of mice treated with C-VISA-BikDD in contrast to apoptotic positive cells of the pancreas of mice treated with cerulein (4.5% TUNEL-positive cells). Treatment with C-VISA-BikDD produces virtually no systemically acute toxicity or acute pancreatitis. Conclusion: Systemic administration of C-VISA-BikDD:DNA-liposome complex appears to be safe. Clinical study in pancreatic cancer is planned.